Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease—Proceedings of the first Thiopurine Task Force meeting-Reference-Cited by-同舟云学术

Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease—Proceedings of the first Thiopurine Task Force meeting

Published:2011-04 Issue:4 Volume:43 Page:270-276
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

van Asseldonk Dirk P.,Sanderson Jeremy,de Boer Nanne K.H.,Sparrow Miles P.,Lémann Marc,Ansari Azhar,Almer Sven H.,Florin Timothy H.J.,Gearry Richard B.,Mulder Chris J.,Mantzaris Gerassimos,van Bodegraven Ad A.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference62 articles.

1. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial;Remuzzi;Lancet,2004

2. Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's disease;Yu;Pharmacoeconomics,2009

3. Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts;Jharap;Inflamm Bowel Dis,2010

4. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease;Prefontaine;Cochrane Database Syst Rev,2009

5. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis;Timmer;Cochrane Database Syst Rev,2007

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the use of 6-thioguanine riboside versus 6-thioguanine as calibration standard to monitor 6-thioguanine nucleotides in red blood cells;Journal of Pharmaceutical and Biomedical Analysis Open;2023-06

2. Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease;Digestive and Liver Disease;2021-12

3. Thiopurines’ Metabolites and Drug Toxicity: A Meta-Analysis;Journal of Clinical Medicine;2020-07-13

4. Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients;Alimentary Pharmacology & Therapeutics;2020-04-28

5. Is there room for immunomodulators in ulcerative colitis?;Expert Opinion on Biological Therapy;2019-12-30